|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400085677 |
|
最近更新日期: Date of Last Refreshed on: |
2024-06-14 18:37:24 |
|
注册时间: Date of Registration: |
2024-06-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
颌骨缺损精准数字化修复技术的探索和临床应用研究 |
|
Public title: |
Exploration and clinical application of precise digital rehabilitation for maxillary and mandibular defects |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
颌骨缺损精准数字化修复技术的探索和临床应用研究 |
|
Scientific title: |
Exploration and clinical application of precise digital rehabilitation for maxillary and mandibular defects |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王子轩 |
研究负责人: |
叶红强 |
|
Applicant: |
Wang Zixuan |
Study leader: |
Ye Hongqiang |
|
申请注册联系人电话: Applicant telephone: |
+86 150 1138 0144 |
研究负责人电话:
Study leader's |
+86 177 0136 6099 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15011380144@163.com |
研究负责人电子邮件: Study leader's E-mail: |
yhqfy@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市海淀区中关村南大街22号 |
研究负责人通讯地址: |
北京市海淀区中关村南大街22号 |
|
Applicant address: |
22 Zhongguancun Nandajie, Haidian District, Beijing |
Study leader's address: |
22 Zhongguancun Nandajie, Haidian District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
100081 |
研究负责人邮政编码: Study leader's postcode: |
100081 |
|
申请人所在单位: |
北京大学口腔医院 |
||
|
Applicant's institution: |
Peking university hospital of stomatology |
||
|
研究负责人所在单位: |
北京大学口腔医院 |
||
|
Affiliation of the Leader: |
Peking university hospital of stomatology |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
PKUSSIRB-202498053 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学口腔医院生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Ethics Committee, Peking University Hospital of Stomatology |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-05-20 00:00:00 | ||
|
伦理委员会联系人: |
贾效伟 |
||
|
Contact Name of the ethic committee: |
Jia Xiaowei |
||
|
伦理委员会联系地址: |
北京市海淀区中关村南大街32号 |
||
|
Contact Address of the ethic committee: |
32 Zhongguancun Nandajie, Haidian District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 82195759 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking university hospital of stomatology |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市海淀区中关村南大街22号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
22 Zhongguancun Nandajie, Haidian District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
首都卫生发展科研专项基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Capital’s Funds for Health Improvement and Research |
||||||||||||||||||||||
|
研究疾病: |
上下颌骨缺损 |
||||||||||||||||||||||
|
Target disease: |
maxillary and mandibular defects |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探索数字化技术在颌骨缺损精准修复中的应用流程,开展临床应用并评价其应用效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
To explore the application process of digital technology in the precise reconstruction of maxillary and mandibular defects, carry out clinical applications, and evaluate its effect. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)上颌骨或下颌骨缺损; (2)至少剩余一颗前磨牙或磨牙可预备支托凹和导平面; (3)基牙松动不超过II度,牙槽骨吸收不超过1/2; (4)包括基牙在内的余留牙无牙体牙髓疾病或经过完善治疗,无不良修复体,无牙周病或牙周病经过治疗得到控制; (5)具备完全自主的行为能力和表达能力。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Patients acquired maxillary or mandibular defects (2) At least one remaining premolar or molar prepares the fovea and guide plane (3) The abutment tooth is loose, not more than degree II, and the alveolar bone resorption is not more than 1/2 (4) The remaining teeth, including the abutments, are toothless or well-treated, have no undesirable restorations, and no periodontal disease or periodontal disease is controlled by treatment (5) Possess the ability to act and express themselves completely autonomously |
||||||||||||||||||||||
|
排除标准: |
(1)上颌骨缺损伴上颌牙列缺失,或下颌骨缺损伴下颌牙列缺失的患者; (2)不能配合进行赝复体修复的患者; (3)不愿意参加本研究的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Endentulous patients with maxillary or mandibular defects (2) Patients who are unable to cooperate with prosthetic restorations (3) Patients who are unwilling to participate in this study |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-06-01 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-06-20 00:00:00 至 To 2026-10-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
在牙体预备导板试验中,将受试者进行编号(1到30,如果拟纳入30名受试者),每个编号受试者由项目组其他人员使用excel软件中【=RANDBETWEEN(1,100)】函数产生随机数(函数意思为随机生成1到100之间的数字),将随机数从小到大进行排序,前15名受试者将被分到实验组,另一半将被分进对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
In the tooth preparation guide trial, the subjects were numbered (1 to 30, if 30 subjects are to be included), and each numbered subject was generated by other members of the experimental group using the [=RANDBETWEEN(1,100)] function in Excel software (the function means to randomly generate numbers between 1 and 100), and the random numbers were sorted from small to large, and the first 15 subjects will be assigned to the experimental group, and the other half will be divided into the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
提前设计病历记录表,包含所有采集的指标。 所有采集的数据录入电脑进行管理和保存,采用双录入的方法,避免录入差错。 采用牛蛙科研(网页地址:https://www.newwa.cn/)作为本研究的临床数据电子采集和管理系统。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Design a medical record sheet in advance to include all collected indicators. All collected data is entered into the computer for management and storage, and the method of double entry is adopted to avoid input errors. Newwa Research (webpage address: https://www.newwa.cn/) was used as the electronic clinical data collection and management system for this study. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |